Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
34
APLS Quote, Financials, Valuation and Earnings
Last price:
$20.06
Seasonality move
:
-18.71%
Day range:
$19.76 - $20.61
52-week range:
$16.10 - $41.94
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
3.22x
P/B ratio:
15.34x
Volume:
1.6M
Avg. volume:
1.9M
1-year change:
-49.25%
Market cap:
$2.5B
Revenue:
$781.4M
EPS (TTM):
-$1.79
APLS Analysts' Consensus Rating
The 18 analysts providing 12-month price projections for Apellis Pharmaceuticals shares anticipate an average target of $35.45, ranging from a low estimate of $17.00 to a high estimate of $60.00. This average target implies a growth of 76.9% compared to the current stock price of $20.04.
Consensus Price Target
$35.45
Highest Price Target
$60.00
Lowest Price Target
$17.00
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Analyst Ratings
| 6M Ago | 1M Ago | Current | |
|---|---|---|---|
| Buy | 11 | 9 | 9 |
| Hold | 8 | 9 | 9 |
| Sell | 0 | 0 | 0 |
| Consensus | Buy | Leans Bullish | Leans Bullish |
APLS Recommendation Trends
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 18
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 19.81% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 17.85% over the past day.
